Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

Agree. It was a bit demoralising to watch. Deeply disappointed...

First 12 Last

Share
Profile

Follow
Bathurst

787 Posts.

77

17/06/24

16:44

Post #: 74355101
Share

Originally posted by F18FDG: ↑

Whatever Sharewise promote thatmselves to be, I found their service deeply disappointing. From not even knowing the name of the company, to asking if the 3 Chimeric products were already in market, it was a truly amateurish production.

I see so many of these online 'investor forums' presented by inexperienced, inarticulate and poorly prepared hosts, it makes me wonder why public companies would bother with the service?

Our business is highly complex and nuanced. Banal, unsophisticated presenters/presentations such as these, inhibit opportunities to craft messaging that reflects the nature of the industry and potential of the investment.

Expand

Agree. It was a bit demoralising to watch.
Deeply disappointed (saddened even) re the now obvious glioblastoma treatment difficulties that are coming to light.
Also I don't really feel that the cash-burn question was answered in full.

CHM Price at posting: 1.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 14 more messages in this thread...

First 12 Last

Add CHM (ASX) to my watchlist